Advarra stands as a leading provider of clinical research compliance and technology solutions, specializing in institutional review board (IRB), institutional biosafety committee (IBC), and consulting services for the life sciences industry [1]. The organization's comprehensive suite of services and technology platforms optimizes clinical research processes while maintaining the highest standards of regulatory compliance and participant protection.
The company's leadership team brings extensive experience in clinical research, regulatory compliance, and technology innovation [3], comprising:
- Gadi Saarony, CEO - Over 25 years of clinical research leadership experience [3]
- Scott Uebele, COO - 20+ years of global operations experience [2]
- Lauri Carlile, Chief Research Services Officer - 25+ years research industry expertise [4]
- Dwight Van Inwegen, CFO - 30+ years executive leadership [6]
- Elisa Cascade, Chief Product Officer - 30+ years clinical research technology experience [7]
- Marco Capasso, Chief Legal and Risk Officer - 25+ years legal expertise [8]
- Bryan Spielman, Chief Growth Officer - 25+ years business development experience [9]
- Vicki Vezina, Chief Human Resources Officer - 30 years HR strategy experience [5]
Advarra maintains extensive relationships across the medical research landscape, partnering with leading institutions and researchers. Their reach encompasses:
- 3,500 partner institutions [1]
- 50,000 active investigators [1]
- Majority of NCI-designated cancer centers [1]
- Comprehensive Endpoint Adjudication Committee (EAC) services [2]
- Significant presence among top NIH-funded institutions [3]
The organization maintains robust cloud-based technology solutions with comprehensive security and compliance frameworks, demonstrated by:
- ISO 27001:2013 certification [1]
- SOC 2 Type 2 certification [1]
- Fully managed cloud security infrastructure [3]
- GxP compliance auditing capabilities [5]
Advarra maintains strong professional affiliations with key industry organizations:
- Association of Clinical Research Professionals (ACRP) [6]
- Drug Information Association (DIA) [6]
- Association for the Accreditation of Human Research Protection Programs (AAHRPP) [6]
- Society for Clinical Research Sites (SCRS) [6]
Recent strategic developments have positioned Advarra for continued growth, including placement on the 2024 Inc. 5000 list [6] and securing major investment from Blackstone and CPP Investments [4]. Notable technological advances include: